MitoCareX Bio
Novel Therapies for Hard-to-treat Resistant Cancers
Active
Acquired
Startup
Tel Aviv-Yafo
Founded 2022-02
MitoCareX Bio is a drug discovery company focusing on the discovery and development of novel therapies for hard-to-treat lung cancer by targeting mitochondrial transporters (SLC25 protein family). To discover new potential drugs targeting human mitochondrial carriers, MitoCareX Bio has developed its MITOLINE algorithm and other advanced computational capabi…
SectorHealth Tech & Life Sciences
StageAcquired
Employees5
Founded2022-02
HQTel Aviv-Yafo
Confidence76
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals